Want to see JP:4483 full AI Analyst Report?
4483 Stock Chart & Stats
¥4697.00
-¥27.00(-0.71%)
At close: 4:00 PM EST
¥4697.00
-¥27.00(-0.71%)
Day’s Range― - ―
52-Week Range¥2,369.00 - ¥4,950.00
Previous CloseN/A
Volume139.20K
Average Volume (3M)195.64K
Market Cap
¥245.76B
Enterprise Value¥210.23B
Total Cash (Recent Filing)¥30.78B
Total Debt (Recent Filing)¥51.03B
Price to Earnings (P/E)35.1
Beta0.85
Next Earnings
Nov 05, 2026EPS Estimate
26.38Next Dividend Ex-DateN/A
Dividend Yield0.48%
Share Statistics
EPS (TTM)105.92
Shares Outstanding65,448,210
10 Day Avg. Volume166,610
30 Day Avg. Volume195,640
Financial Highlights & Ratios
PEG Ratio2.34
Price to Book (P/B)2.53
Price to Sales (P/S)4.20
P/FCF Ratio26.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,381.43Price Target Upside-6.72% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)114.57
Revenue Forecast (FY)¥60.42B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthStrong multi-year revenue expansion indicates that JMDC is continuing to broaden monetization of its healthcare data and analytics offerings. Sustained top-line growth can support investment in datasets, platforms, and customer capabilities while reinforcing its position across healthcare stakeholders.
Solid ProfitabilityHealthy gross and operating margins show that JMDC’s data and analytics model is generating meaningful operating profit as revenue scales. This provides internal resources for product development and market expansion, while offering resilience if growth moderates over the next several quarters.
Recent Positive Free Cash FlowRecent free cash flow broadly matching net income is a favorable quality-of-earnings signal, indicating that reported profitability is translating into cash generation. This strengthens JMDC’s ability to fund operations and growth internally without relying entirely on external financing.
Bears Say
Increasing LeverageAlthough debt remains below equity, the upward trend in leverage reduces some of JMDC’s financial flexibility relative to its earlier position. Higher borrowing can increase financing obligations and leave less capacity to absorb weaker growth or fund initiatives through the balance sheet.
Volatile Cash ConversionLumpy cash conversion makes the timing and reliability of internally generated funds less predictable, even though recent free cash flow is positive. Working-capital swings or timing effects could complicate investment planning and increase dependence on liquidity or financing during weaker periods.
Moderating Growth And MarginsSlower recent growth combined with declining net margin suggests that incremental expansion may be becoming more demanding. Cost, mix, or investment pressure could limit the rate at which revenue growth converts into earnings, reducing operating leverage if the trend persists.
JMDC Inc. News
4483 FAQ
What was JMDC Inc.’s price range in the past 12 months?
JMDC Inc. lowest stock price was ¥2369.00 and its highest was ¥4950.00 in the past 12 months.
What is JMDC Inc.’s market cap?
JMDC Inc.’s market cap is ¥245.76B.
When is JMDC Inc.’s upcoming earnings report date?
JMDC Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 14 days.
How were JMDC Inc.’s earnings last quarter?
JMDC Inc. released its earnings results on Aug 05, 2026. The company reported ¥17.28 earnings per share for the quarter, beating the consensus estimate of ¥9.079 by ¥8.201.
Is JMDC Inc. overvalued?
According to Wall Street analysts JMDC Inc.’s price is currently Overvalued.
Does JMDC Inc. pay dividends?
JMDC Inc. pays a Annually dividend of ¥18 which represents an annual dividend yield of 0.48%. See more information on JMDC Inc. dividends here
What is JMDC Inc.’s EPS estimate?
JMDC Inc.’s EPS estimate is 26.38.
How many shares outstanding does JMDC Inc. have?
JMDC Inc. has 65,448,210 shares outstanding.
What happened to JMDC Inc.’s price movement after its last earnings report?
JMDC Inc. reported an EPS of ¥17.28 in its last earnings report, beating expectations of ¥9.079. Following the earnings report the stock price went up 1.993%.
Which hedge fund is a major shareholder of JMDC Inc.?
Currently, no hedge funds are holding shares in JP:4483
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JMDC Inc.
JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.
4483 Stock 12 Month Forecast
Average Price Target
¥4,381.43
▼(-6.72% Downside)